Synthetic alpha interferon(ILC Therapeutics)

N/A

Report date: 2024/12/02 14:00:03

Base Information

Drug NameSynthetic alpha interferon(ILC Therapeutics)
Drug Alias NameAlfacyte
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionInterferon alpha replacements
TargetsInterferon alpha
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesILC Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesILC Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A